Masitinib monotherapy in canine epitheliotropic lymphoma.
about
Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topicEffects of toceranib phosphate (Palladia) monotherapy on multidrug resistant lymphoma in dogs.Canine lymphoma: a review.Clinical outcome and prognosis of dogs with histopathological features consistent with epitheliotropic lymphoma: a retrospective study of 148 cases (2003-2015).Tyrosine Kinase Receptor Expression in Canine Liposarcoma.
P2860
Masitinib monotherapy in canine epitheliotropic lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Masitinib monotherapy in canine epitheliotropic lymphoma.
@en
Masitinib monotherapy in canine epitheliotropic lymphoma.
@nl
type
label
Masitinib monotherapy in canine epitheliotropic lymphoma.
@en
Masitinib monotherapy in canine epitheliotropic lymphoma.
@nl
prefLabel
Masitinib monotherapy in canine epitheliotropic lymphoma.
@en
Masitinib monotherapy in canine epitheliotropic lymphoma.
@nl
P2093
P2860
P356
P1476
Masitinib monotherapy in canine epitheliotropic lymphoma.
@en
P2093
P2860
P304
P356
10.1111/VCO.12157
P478
14 Suppl 1
P577
2015-09-14T00:00:00Z